GOLGA6L1
gene geneOn this page
Summary
GOLGA6L1 (golgin A6 family like 1, HGNC:37444) is a protein-coding gene on chromosome 15q11.2, encoding Golgin subfamily A member 6-like protein 1 (Q8N7Z2).
At a glance
- Clinical variants (ClinVar): 12 total
- MANE Select transcript:
NM_001001413
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37444 |
| Approved symbol | GOLGA6L1 |
| Name | golgin A6 family like 1 |
| Location | 15q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000273976 |
| Ensembl biotype | protein_coding |
| Entrez | 283767 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000614055
RefSeq mRNA: 1 — MANE Select: NM_001001413
NM_001001413
CCDS: CCDS73699
Canonical transcript exons
ENST00000611085 — 0 exons
Expression profiles
Bgee: expression breadth broad, 25 present calls, max score 79.56.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.56 | gold quality |
| left testis | UBERON:0004533 | 76.43 | gold quality |
| testis | UBERON:0000473 | 75.52 | gold quality |
| right testis | UBERON:0004534 | 75.31 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 44.36 | gold quality |
| ventricular zone | UBERON:0003053 | 43.20 | gold quality |
| primary visual cortex | UBERON:0002436 | 39.13 | gold quality |
| stromal cell of endometrium | CL:0002255 | 38.84 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 38.43 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 36.72 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| cerebral cortex | UBERON:0000956 | 36.36 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| frontal cortex | UBERON:0001870 | 36.02 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.39 | gold quality |
| right frontal lobe | UBERON:0002810 | 35.17 | gold quality |
| bone marrow | UBERON:0002371 | 35.09 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.97 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 34.03 | gold quality |
| monocyte | CL:0000576 | 33.16 | gold quality |
| leukocyte | CL:0000738 | 32.66 | gold quality |
| liver | UBERON:0002107 | 32.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 32.59 | gold quality |
| right lobe of liver | UBERON:0001114 | 32.39 | gold quality |
| muscle tissue | UBERON:0002385 | 32.23 | gold quality |
| right adrenal gland | UBERON:0001233 | 32.19 | gold quality |
| vermiform appendix | UBERON:0001154 | 32.11 | gold quality |
| thyroid gland | UBERON:0002046 | 32.01 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.49 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
71 targeting GOLGA6L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
Cross-species orthologs
0 orthologs
Paralogs (10): GOLGA6L2 (ENSG00000174450), GOLGA6L4 (ENSG00000184206), GOLGA6L9 (ENSG00000197978), GOLGA6L25 (ENSG00000227717), GOLGA6L24 (ENSG00000237850), GOLGA6L7 (ENSG00000261649), GOLGA6L26 (ENSG00000273756), GOLGA6L6 (ENSG00000277322), GOLGA6L22 (ENSG00000277865), GOLGA6L10 (ENSG00000278662)
Protein
Protein identifiers
Golgin subfamily A member 6-like protein 1 — Q8N7Z2 (reviewed: Q8N7Z2)
All UniProt accessions (1): Q8N7Z2
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GOLGA6 family.
RefSeq proteins (1): NP_001001413* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026737 | GOLGA6L | Family |
UniProt features (13 total): region of interest 5, compositionally biased region 5, chain 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7Z2-F1 | 75.59 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
chr15q11, ZWANG_EGF_INTERVAL_UP, MIR3529_3P, MIR1827, MIR1252_3P, MIR4666A_5P, MIR3064_3P, MIR4426, MIR6747_3P, MIR1243, MIR23B_5P, MIR23A_5P, PULVER_FOREY_PERTURB_ACCUMULATION_G2_M, PULVER_FOREY_PERTURB_ATTRITION_M_EG1
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
623 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GOLGA6L1 | GTF3C6 | Q969F1 | 573 |
| GOLGA6L1 | OR4M2 | Q8NGB6 | 507 |
| GOLGA6L1 | GTF3C5 | Q9Y5Q8 | 501 |
| GOLGA6L1 | OR2T33 | Q8NG76 | 450 |
| GOLGA6L1 | OR9G1 | Q8NH87 | 447 |
| GOLGA6L1 | TRMT5 | Q32P41 | 446 |
| GOLGA6L1 | GPHRA | B7ZAQ6 | 444 |
| GOLGA6L1 | OR4N4 | Q8N0Y3 | 435 |
| GOLGA6L1 | ANKRD36B | Q8N2N9 | 402 |
| GOLGA6L1 | PCYT2 | Q99447 | 401 |
| GOLGA6L1 | TRMT6 | Q9UJA5 | 400 |
| GOLGA6L1 | ZFAND1 | Q8TCF1 | 391 |
| GOLGA6L1 | DHX38 | Q92620 | 384 |
| GOLGA6L1 | TMED2 | Q15363 | 380 |
| GOLGA6L1 | COMMD2 | Q86X83 | 378 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A1B0GV03, A6NEF3, A6NEM1, A6NI86, A8MZA4, B4DH59, D3YVF0, F6QRE9, H0YKK7, H0YM25, P0C6Y7, P0C7A2, P0DX00, P0DX01, P0DX02, P14590, P21263, P22793, P24587, P24710, P48997, P48998, Q07283, Q0II65, Q0P6D6, Q13342, Q3BBV2, Q4R9C9, Q5W0A0, Q6AXX0, Q6NSX1, Q6P5H2, Q6P902, Q86T75, Q8CHD8, Q8N2N9, Q8N660, Q8N7Z2
Diamond homologs: A0A1B0GV03, A1IH00, A6NC78, A6NCC3, A6NDK9, A6NDN3, A6NEF3, A6NEM1, A6NI86, A6NN73, A7E2F4, A8MQT2, A8MZA4, F8WBI6, H0YKK7, H0YM25, H3BPF8, H3BSY2, H3BV12, I6L899, P0CG33, P0CJ92, P0DX00, P0DX01, P0DX02, P0DX52, P0DX53, Q08379, Q62839, Q8N7Z2, Q8N9W4, Q921M4, Q9NYA3, A6NMD2, D6RF30, H3BQL2, Q0D2H9, Q9HBQ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
12 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1085 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:23131325:CTCA:C | donor_loss | 1.0000 |
| 15:23131326:TCA:T | donor_loss | 1.0000 |
| 15:23131327:CAC:C | donor_loss | 1.0000 |
| 15:23131328:A:AC | donor_gain | 1.0000 |
| 15:23131329:C:CC | donor_gain | 1.0000 |
| 15:23131329:C:CG | donor_loss | 1.0000 |
| 15:23131467:TTATG:T | acceptor_gain | 1.0000 |
| 15:23131468:TATG:T | acceptor_gain | 1.0000 |
| 15:23131469:ATG:A | acceptor_gain | 1.0000 |
| 15:23131470:TG:T | acceptor_gain | 1.0000 |
| 15:23131470:TGC:T | acceptor_loss | 1.0000 |
| 15:23131471:GC:G | acceptor_loss | 1.0000 |
| 15:23131472:C:CC | acceptor_gain | 1.0000 |
| 15:23131472:C:CG | acceptor_loss | 1.0000 |
| 15:23131474:A:C | acceptor_gain | 1.0000 |
| 15:23131479:C:CT | acceptor_gain | 1.0000 |
| 15:23131479:C:T | acceptor_gain | 1.0000 |
| 15:23131480:A:T | acceptor_gain | 1.0000 |
| 15:23131485:C:CT | acceptor_gain | 1.0000 |
| 15:23131486:A:T | acceptor_gain | 1.0000 |
| 15:23131487:G:C | acceptor_gain | 1.0000 |
| 15:23131487:G:GC | acceptor_gain | 1.0000 |
| 15:23131800:A:AC | donor_gain | 1.0000 |
| 15:23131801:C:CC | donor_gain | 1.0000 |
| 15:23131806:T:TA | donor_gain | 1.0000 |
| 15:23133237:AC:A | donor_gain | 1.0000 |
| 15:23133238:CC:C | donor_gain | 1.0000 |
| 15:23133618:CTCA:C | donor_loss | 1.0000 |
| 15:23133619:TCA:T | donor_loss | 1.0000 |
| 15:23133620:CA:C | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000165979 (15:23127653 C>T), RS1005852724 (15:23134561 C>T), RS1012763673 (15:23127831 G>T), RS1013044497 (15:23132842 T>C), RS1022963340 (15:23132789 C>A,G,T), RS1023014237 (15:23127819 T>A), RS1029924846 (15:23127565 C>T), RS1032116779 (15:23127634 G>A), RS1035961200 (15:23133105 C>G), RS1037542628 (15:23133957 T>C), RS1050050613 (15:23135787 C>G), RS1050103773 (15:23132323 C>A,G,T), RS1056963530 (15:23130223 C>T), RS111945226 (15:23137465 C>G,T), RS111989150 (15:23134185 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 1 |
| Cadmium | decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.